Gardnerville Health & Rehab: 5 Violations - NV
GARDNERVILLE, NV - A recent health inspection at Gardnerville Health & Rehabilitation Center identified critical failures in the facility's vaccination program, with residents not receiving timely pneumococcal and COVID-19 vaccines despite documented eligibility and pending immunization status.
Pneumococcal Vaccine Administration Delays Put Diabetic Resident at Risk
The inspection revealed that Resident #12, who has type two diabetes mellitus with circulatory complications and chronic diastolic heart failure, did not receive appropriate pneumococcal vaccination despite being overdue for the recommended vaccine schedule. The resident's medical records showed they had received the PPSV23 pneumococcal vaccine three times previously - in October 2013, December 2018, and June 2021 - but had not received any of the newer conjugate vaccines required to complete the current vaccination protocol.
According to the facility's Immunization Audit Report, four different pneumococcal vaccines were marked as "pending immunization" for this resident: PCV13, PPSV23, PCV15, and PCV20. The Infection Preventionist confirmed that "pending immunization indicated the resident gave consent and was due/eligible for the vaccine." Despite this documented eligibility and apparent consent, none of these vaccines had been administered to the resident.
The timing failure is particularly concerning given current Centers for Disease Control and Prevention guidelines. For adults over 65 who have previously received PPSV23 vaccines, the CDC recommends administering either PCV20 or PCV21 at least one year after the last PPSV23 dose, or alternatively, PCV15 followed by additional doses. Since Resident #12's last PPSV23 vaccine was administered in June 2021, they had been eligible for the conjugate vaccine for nearly four years at the time of the inspection in May 2025.
COVID-19 Vaccine Never Administered Despite Documented Eligibility
The inspection also uncovered that Resident #4, who suffers from type two diabetes mellitus and hypertension, had never received any doses of the COVID-19 vaccine despite being identified as eligible. The resident's Immunization Audit Report contained no documentation of any COVID-19 vaccination history, with the vaccine status listed as "pending immunization" since April 13, 2025.
A Multi-Vaccine Consent Form from the same date indicated Resident #4 was eligible for the COVID-19 vaccine, yet the form lacked any signature showing whether the resident had consented to or declined vaccination. When questioned during the inspection, the Infection Preventionist confirmed that the resident "should have received or declined the vaccine" and acknowledged that no COVID-19 vaccine had been administered.
This oversight is particularly troubling given that individuals with diabetes face significantly higher risks of severe COVID-19 complications. The CDC explicitly recommends that all nursing home residents receive the 2024-2025 COVID-19 vaccine, with adults 65 and older requiring two doses administered ideally six months apart, or at minimum two months apart.
Medical Implications of Vaccination Failures
The failure to provide timely pneumococcal vaccination poses serious health risks, particularly for residents with underlying conditions. Pneumococcal disease can cause life-threatening infections including pneumonia, meningitis, and bloodstream infections. Adults with diabetes face a three to six times higher risk of invasive pneumococcal disease compared to healthy adults of the same age. The circulatory complications and heart failure affecting Resident #12 further compound this vulnerability, as cardiovascular conditions significantly increase the risk of pneumococcal pneumonia and its complications.
The newer conjugate vaccines (PCV13, PCV15, PCV20, and PCV21) provide broader protection against pneumococcal strains than the older PPSV23 vaccine alone. These conjugate vaccines create stronger, longer-lasting immunity and are particularly important for immunocompromised individuals. The multi-year delay in administering these vaccines left Resident #12 without optimal protection against potentially fatal infections.
For COVID-19, the risks are equally severe. Diabetes increases the likelihood of severe COVID-19 outcomes by two to three times, including higher rates of hospitalization, intensive care admission, and death. Hypertension, which Resident #4 also has, independently increases COVID-19 severity. The combination of these conditions creates a particularly high-risk profile that makes vaccination essential rather than optional.
Nursing home residents face additional environmental risks due to congregate living settings where respiratory infections spread rapidly. Without vaccination, these residents remain vulnerable not only to infection but also to becoming vectors for facility-wide outbreaks that can affect multiple vulnerable individuals.